Sigridov I, Ivanov St, Batashki I
Akush Ginekol (Sofiia). 2007;46 Suppl 2:29-32.
To study the efficacy of vaginal application of Lactofem (viable Lactobacilli) in cases of vaginal microflora disturbances.
32 patient between 18-32 years (12 of them, suffering from vulvovaginal candidosis-VVC, 20--with bacterial vaginosis- BV) were included in a placebo controlled trial. In all of them no Lactobacilli were found on vaginal smear preparation.
After one month 90% of women with VVC, treated with Lactofem were cured, compared to 83% in the placebo group. Application of Lactofem resulted in cure rate of 90% in the BV group. In the placebo group cure rate of 67% was achieved. After 3 months of application, VVC was eradicated in 100% of cases in Lactofem group and in 85% of cases in the placebo group. BV was cured in 90% of women, using Lactofem and in 50% of patients, using placebo. Only one patient had mild and temporary side effect.
研究阴道应用乳酸杆菌制剂(活乳酸杆菌)治疗阴道微生物群紊乱的疗效。
32例年龄在18至32岁之间的患者(其中12例患有外阴阴道念珠菌病-VVC,20例患有细菌性阴道病-BV)被纳入一项安慰剂对照试验。所有患者的阴道涂片检查均未发现乳酸杆菌。
一个月后,接受乳酸杆菌制剂治疗的VVC患者中有90%治愈,而安慰剂组为83%。乳酸杆菌制剂治疗使BV组的治愈率达到90%。安慰剂组的治愈率为67%。应用3个月后,乳酸杆菌制剂组100%的病例VVC得到根除,安慰剂组为85%。使用乳酸杆菌制剂治疗的BV患者中有90%治愈,使用安慰剂的患者中有50%治愈。只有一名患者出现轻微且短暂的副作用。